Capricor Therapeutics, Inc. (CAPR) stock
CAPRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$9.53−0.71 (-6.93%)
Close on Nov 13, 2026Market cap $554.07MP/E –Yield –
Capricor Therapeutics cash
Cash and short-term investments held at the end of each period.
Capricor Therapeutics's cash was $197.58M at Sep 30, 2026. For fiscal 2025 it was $318.13M, up 110.0% from the year before. Over ten years it grew 37.1% a year on average. The highest annual figure on record is $318.13M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $318.13M | +110.0% |
| FY2024 | Dec 31, 2024 | $151.50M | +283.5% |
| FY2023 | Dec 31, 2023 | $39.50M | -4.6% |
| FY2022 | Dec 31, 2022 | $41.40M | +18.6% |
| FY2021 | Dec 31, 2021 | $34.90M | +6.8% |
| FY2020 | Dec 31, 2020 | $32.67M | +230.4% |
| FY2019 | Dec 31, 2019 | $9.89M | +31.1% |
| FY2018 | Dec 31, 2018 | $7.54M | -49.3% |
| FY2017 | Dec 31, 2017 | $14.87M | -15.3% |
| FY2016 | Dec 31, 2016 | $17.54M | +29.3% |
| FY2015 | Dec 31, 2015 | $13.57M | +68.9% |
| FY2014 | Dec 31, 2014 | $8.03M | +282.6% |
| FY2013 | Dec 31, 2013 | $2.10M | -52.3% |
| FY2012 | Dec 31, 2012 | $4.40M | +183.8% |
| FY2011 | Dec 31, 2011 | $1.55M | -54.1% |
| FY2010 | Dec 31, 2010 | $3.38M | +6.4% |
| FY2009 | Dec 31, 2009 | $3.18M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $197.58M | +100.4% |
| Q2 FY2026 | Jun 30, 2026 | $237.93M | +93.8% |
| Q1 FY2026 | Mar 31, 2026 | $278.61M | +92.4% |
| Q4 FY2025 | Dec 31, 2025 | $318.13M | +110.0% |
| Q3 FY2025 | Sep 30, 2025 | $98.60M | +16.0% |
| Q2 FY2025 | Jun 30, 2025 | $122.80M | +316.3% |
| Q1 FY2025 | Mar 31, 2025 | $144.80M | +262.9% |
| Q4 FY2024 | Dec 31, 2024 | $151.50M | +283.5% |
| Q3 FY2024 | Sep 30, 2024 | $85.00M | +198.2% |
| Q2 FY2024 | Jun 30, 2024 | $29.50M | -22.0% |
| Q1 FY2024 | Mar 31, 2024 | $39.90M | -11.7% |
| Q4 FY2023 | Dec 31, 2023 | $39.50M | -4.6% |
| Q3 FY2023 | Sep 30, 2023 | $28.50M | -38.8% |
| Q2 FY2023 | Jun 30, 2023 | $37.80M | -26.5% |
| Q1 FY2023 | Mar 31, 2023 | $45.20M | -22.5% |
| Q4 FY2022 | Dec 31, 2022 | $41.40M | +18.6% |
| Q3 FY2022 | Sep 30, 2022 | $46.60M | +14.1% |
| Q2 FY2022 | Jun 30, 2022 | $51.40M | +35.0% |
| Q1 FY2022 | Mar 31, 2022 | $58.33M | +39.3% |
| Q4 FY2021 | Dec 31, 2021 | $34.90M | +6.8% |
| Q3 FY2021 | Sep 30, 2021 | $40.84M | +15.7% |
| Q2 FY2021 | Jun 30, 2021 | $38.08M | +5.0% |
| Q1 FY2021 | Mar 31, 2021 | $41.88M | +216.8% |
| Q4 FY2020 | Dec 31, 2020 | $32.67M | +230.4% |
| Q3 FY2020 | Sep 30, 2020 | $35.30M | +417.0% |
| Q2 FY2020 | Jun 30, 2020 | $36.25M | +515.4% |
| Q1 FY2020 | Mar 31, 2020 | $13.22M | +84.3% |
| Q4 FY2019 | Dec 31, 2019 | $9.89M | +31.1% |
| Q3 FY2019 | Sep 30, 2019 | $6.83M | -34.2% |
| Q2 FY2019 | Jun 30, 2019 | $5.89M | -52.2% |
| Q1 FY2019 | Mar 31, 2019 | $7.17M | -45.5% |
| Q4 FY2018 | Dec 31, 2018 | $7.54M | -49.3% |
| Q3 FY2018 | Sep 30, 2018 | $10.37M | +9.1% |
| Q2 FY2018 | Jun 30, 2018 | $12.33M | +35.7% |
| Q1 FY2018 | Mar 31, 2018 | $13.16M | +239.6% |
| Q4 FY2017 | Dec 31, 2017 | $14.87M | -15.3% |
| Q3 FY2017 | Sep 30, 2017 | $9.51M | – |
| Q2 FY2017 | Jun 30, 2017 | $9.09M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.88M | – |
| Q4 FY2016 | Dec 31, 2016 | $17.54M | – |
See a number that looks wrong?